ClinicalTrials.gg
CompletedNCT02843737SDIUpdated May 12, 2017

Multicenter Observational Study to Validate a New Index for Sleep Fragmentation Analysis: Sleep Diversity Index (SDI)

An observational study in Sleep Fragmentation, sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Completed at 3 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-12.

Sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

The investigators want to validate the Sleep Diversity Index as a diagnosis tool of sleep fragmentation on 405 patients who will perform a polysomnography under spontaneous breathing.

Read the detailed description

Sleep fragmentation is one of the main problems of sleep disorders especially in respiratory failure. During this last decade, several indicators of sleep fragmentation were introduced but none of them seems to take into account the succession of sleep stages. To tackle with this problem, The investigators used the Shannon entropy index for modelling sleep stages diversity from an hypnogram and for assessing more accurately sleep quality by quantifying its fragmentation. The investigators developed a new tool we called Sleep Diversity Index (SDI).

In a retrospective study, the investigators calculated Sleep diversity index for 55 healthy subjects and 56 patients with suspected sleep apnea syndrom. Using the receiver operating characteristic (ROC) curves the threshold of fragmentation was determined at 20%. If SDI is lower than 20%, then sleep is considered as non-fragmented and otherwise, sleep is considered as fragmented.

To validate our SDI it is necessary to compare this diagnosis tool to a "gold standard" based on the clinician diagnosis and a mathematical diagnosis index created from objective criteria of polysomnography. The investigators propose a multicenter study to validate the SDI as a diagnosis tool of sleep fragmentation.

02

Conditions studied

  • Sleep Fragmentation

Browse trials for

03

In context

Sleep Deprivation

309 studies on the registry are indexed under Sleep Deprivation; 62 are open to participants now.

This study's enrollment of 300 is above the median of 60 across 51 observational studies indexed under Sleep Deprivation.

Browse Sleep Deprivation studies →

Lead sponsor

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer is the lead sponsor of 78 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who performed a spontaneous breathing polysomnography

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Spontaneous polysomnography

Exclusion criteria

Exclusion Criteria:

  • Insomnia
  • Patients with psychoactive drug having an important effect on sleep
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
300 participants (actual)
Patient registry
No

Interventions

  • OtherPolysomnography under spontaneous breathing

    Patient will come to the sleep laboratory to perform the polysomnography under spontaneous breathing prescribed by the clinician

06

What researchers measure

Primary outcomes

  1. Comparison between mathematical analysis and clinician interpretation of polysomnographic datas recorded under spontaneous breathing

    In order to determine the fragmentation of patient's sleep with two different approach and test the sleep diversity index .

    Time frame: One night

07

Study locations

3 sites
  • CHU Dijon
    Dijon, 21079, France
  • CHU Poitiers
    Poitiers, 86021, France
  • Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (CHITS)
    Toulon, 83056, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2014 to primary completion in Dec 2014, 1 month.

Of 23 observational studies under Sleep Deprivation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 70. This study's 1 month is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2016
First posted
Jul 26, 2016
StartActual
Nov 21, 2014
Primary completionActual
Dec 2014
CompletionActual
Mar 16, 2017
Last update
May 12, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02843737
Lead sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Collaborators
University of Toulon, bio N com Association
Responsible party
Sponsor
First posted
Jul 26, 2016
Start date
Nov 21, 2014
Primary completion
Dec 2014
Completion
Mar 16, 2017
Last update
May 12, 2017

Study contacts

Daniel D'AMORE, MD
principal investigator · Centre Hospitalier Intercommunal Toulon La Seyne sur mer

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion